These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 16953249)
1. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Li SD; Huang L Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249 [TBL] [Abstract][Full Text] [Related]
2. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises. Karmali PP; Chaudhuri A Med Res Rev; 2007 Sep; 27(5):696-722. PubMed ID: 17022036 [TBL] [Abstract][Full Text] [Related]
5. Cationic liposomes for gene delivery. Simões S; Filipe A; Faneca H; Mano M; Penacho N; Düzgünes N; de Lima MP Expert Opin Drug Deliv; 2005 Mar; 2(2):237-54. PubMed ID: 16296751 [TBL] [Abstract][Full Text] [Related]
6. The biological routes of gene delivery mediated by lipid-based non-viral vectors. Duan Y; Zhang S; Wang B; Yang B; Zhi D Expert Opin Drug Deliv; 2009 Dec; 6(12):1351-61. PubMed ID: 19780710 [TBL] [Abstract][Full Text] [Related]
12. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247 [TBL] [Abstract][Full Text] [Related]
13. Production of plasmid DNA for pharmaceutical use. Voss C Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478 [TBL] [Abstract][Full Text] [Related]
14. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Douglas KL Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. Luten J; van Nostrum CF; De Smedt SC; Hennink WE J Control Release; 2008 Mar; 126(2):97-110. PubMed ID: 18201788 [TBL] [Abstract][Full Text] [Related]
18. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Hatakeyama H; Akita H; Kogure K; Oishi M; Nagasaki Y; Kihira Y; Ueno M; Kobayashi H; Kikuchi H; Harashima H Gene Ther; 2007 Jan; 14(1):68-77. PubMed ID: 16915290 [TBL] [Abstract][Full Text] [Related]